Back to Search
Start Over
Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review.
- Source :
-
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Aug; Vol. 37 (4), pp. 771-779. Date of Electronic Publication: 2021 Sep 21. - Publication Year :
- 2023
-
Abstract
- Purpose: Post-pericardiotomy syndrome (PPS) is a common complication of cardiac surgery. This systematic review aimed to investigate the efficacy of colchicine, indomethacin, and dexamethasone in the treatment and prophylaxis of PPS.<br />Methods: Literature research was carried out using PubMed. Studies investigating ≥ 10 patients with clinically PPS treated with colchicine, dexamethasone, and indomethacin and compared with placebo were included. Animal or in vitro experiments, studies on < 10 patients, case reports, congress reports, and review articles were excluded. Cochrane risk-of-bias tool for randomized trials (RoB2) was used for the quality assessment of studies.<br />Results: Seven studies were included. Among studies with postoperative colchicine treatment, two of them demonstrated a significant reduction of PPS. In the single pre-surgery colchicine administration study, a decrease of PPS cases was registered. Indomethacin pre-surgery administration was linked to a reduction of PPS. No significant result emerged with preoperative dexamethasone intake.<br />Conclusion: Better outcomes have been registered when colchicine and indomethacin were administered as primary prophylactic agents in preventing PPS and PE. Further RCT studies are needed to confirm these results.<br /> (© 2021. The Author(s).)
Details
- Language :
- English
- ISSN :
- 1573-7241
- Volume :
- 37
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cardiovascular drugs and therapy
- Publication Type :
- Academic Journal
- Accession number :
- 34546452
- Full Text :
- https://doi.org/10.1007/s10557-021-07261-4